Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
12.99
+0.18 (1.41%)
At close: May 2, 2024, 4:00 PM
12.91
-0.08 (-0.62%)
Pre-market: May 3, 2024, 8:06 AM EDT

Teladoc Health Revenue

Teladoc Health had revenue of $2.62B in the twelve months ending March 31, 2024, with 6.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $646.13M with 2.68% year-over-year growth. In the year 2023, Teladoc Health had annual revenue of $2.60B with 8.13% growth.

Revenue (ttm)
$2.62B
Revenue Growth
+6.01%
P/S Ratio
0.84
Revenue / Employee
$467,733
Employees
5,600
Market Cap
2.20B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.60B195.58M8.13%
Dec 31, 20222.41B374.13M18.41%
Dec 31, 20212.03B938.75M85.81%
Dec 31, 20201.09B540.66M97.71%
Dec 31, 2019553.31M135.40M32.40%
Dec 31, 2018417.91M184.63M79.14%
Dec 31, 2017233.28M110.12M89.42%
Dec 31, 2016123.16M45.77M59.15%
Dec 31, 201577.38M33.86M77.78%
Dec 31, 201443.53M23.62M118.67%
Dec 31, 201319.91M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Privia Health Group 1.66B
CONMED 1.26B
STAAR Surgical Company 322.42M
Deciphera Pharmaceuticals 163.36M
RxSight 89.08M
Kymera Therapeutics 79.41M
Arvinas 78.50M
Intellia Therapeutics 36.28M
Revenue Rankings